Clinical Trial Update: Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated ketamine as an augmentation strategy for electroconvulsive therapy (ECT) in unipolar and bipolar depression; results complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Unipolar Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Northwell Health | Conditions: Unipolar Depression, Bipolar Depression | Phase 4 | Status: COMPLETED | Results posted: 2023-03-09